1. Home
  2. UBXG vs APLT Comparison

UBXG vs APLT Comparison

Compare UBXG & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBXG
  • APLT
  • Stock Information
  • Founded
  • UBXG 2018
  • APLT 2016
  • Country
  • UBXG China
  • APLT United States
  • Employees
  • UBXG N/A
  • APLT N/A
  • Industry
  • UBXG
  • APLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • UBXG
  • APLT Health Care
  • Exchange
  • UBXG Nasdaq
  • APLT Nasdaq
  • Market Cap
  • UBXG 60.1M
  • APLT 63.6M
  • IPO Year
  • UBXG 2024
  • APLT 2019
  • Fundamental
  • Price
  • UBXG $1.94
  • APLT $0.43
  • Analyst Decision
  • UBXG
  • APLT Buy
  • Analyst Count
  • UBXG 0
  • APLT 6
  • Target Price
  • UBXG N/A
  • APLT $6.10
  • AVG Volume (30 Days)
  • UBXG 602.5K
  • APLT 800.6K
  • Earning Date
  • UBXG 01-01-0001
  • APLT 11-06-2025
  • Dividend Yield
  • UBXG N/A
  • APLT N/A
  • EPS Growth
  • UBXG N/A
  • APLT N/A
  • EPS
  • UBXG N/A
  • APLT N/A
  • Revenue
  • UBXG $39,603,353.00
  • APLT $121,000.00
  • Revenue This Year
  • UBXG N/A
  • APLT N/A
  • Revenue Next Year
  • UBXG N/A
  • APLT $5,931.24
  • P/E Ratio
  • UBXG N/A
  • APLT N/A
  • Revenue Growth
  • UBXG N/A
  • APLT N/A
  • 52 Week Low
  • UBXG $2.36
  • APLT $0.30
  • 52 Week High
  • UBXG $13.92
  • APLT $10.62
  • Technical
  • Relative Strength Index (RSI)
  • UBXG 31.49
  • APLT 41.75
  • Support Level
  • UBXG $2.60
  • APLT $0.40
  • Resistance Level
  • UBXG $2.96
  • APLT $0.46
  • Average True Range (ATR)
  • UBXG 0.30
  • APLT 0.03
  • MACD
  • UBXG -0.08
  • APLT -0.01
  • Stochastic Oscillator
  • UBXG 5.60
  • APLT 20.38

About UBXG U-BX Technology Ltd. Ordinary Shares

U-BX Technology Ltd is focused on providing value-added services using artificial intelligence-driven technology to businesses within the insurance industry, including insurance carriers and brokers. It helps institutional clients obtain visibility on various social media platforms and generate revenue based on consumers' clicks, views, or its clients' promotion time through those channels. The company derives a majority of its revenue by providing digital promotion services to its clients and also engages in providing risk assessment services, and value-added bundled benefits. It has developed an algorithm named Magic Mirror, to calculate payout risks for insurance carriers to underwrite auto insurance coverage. Geographically, all of the company's revenue is derived from Mainland China.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: